US Patent 7888072 Heparan sulfate glycosaminoglycan lyase and uses thereof
Patent 7888072 was granted and assigned to Momenta Pharmaceuticals on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+451 characters)
Article
Patent abstract
The invention provides recombinant B. thetaiotaomicron GAG lyase polypeptides. The invention also provides nucleic acid molecules encoding such polypeptides, recombinant expression vectors containing B. thetaiotaomicron GAG lyase nucleic acid molecules, and host cells into which the expression vectors have been introduced. Characterization, diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
James Myette0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07888072 Heparan sulfate glycosaminoglycan lyase and uses thereof US Patent 7888072 Heparan sulfate glycosaminoglycan lyase and uses thereof
Infobox
Patent Number
07888072
Patent Number
7888072
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07888072 Heparan sulfate glycosaminoglycan lyase and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07888072
Date of patent
February 15, 2011
Patent application number
12436751
Date Filed
May 6, 2009
Patent primary examiner
Find more entities like US Patent 7888072 Heparan sulfate glycosaminoglycan lyase and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
